文献速递肝病消化道肿瘤与早癌

退伍军人健康管理局中经活检证实的晚期非酒精性脂肪性肝病的危险因素

Risk factors for biopsy-proven advanced non-alcoholic fatty liver disease in the Veterans Health Administration.
PubMed 文献 · Aliment Pharmacol Ther · 2017-11-08

该回顾性病例对照研究纳入退伍军人健康管理局(VHA)2005至2015年数据库中经活检定义的399例非酒精性脂肪性肝病(NAFLD)或正常肝脏成人患者,评估晚期纤维化的危险因素。结果显示糖尿病(OR 11.8,P < .001)和体重指数(OR 1.4,P < .001)是晚期纤维化最显著的预测因素。仅约20%的NAFLD患者参加了饮食/运动项目,约2%接受了减重手术。

要点

  • 糖尿病(OR 11.8,P < .001)和体重指数(OR 1.4,P < .001)是晚期纤维化最显著的预测因素。
  • NAFLD合并纤维化或肝细胞癌的患者中糖尿病(54.4%-79.6%)和高血压(85.8%-100%)更常见。
  • 仅12.3%-19.5%的NAFLD患者参加饮食/运动项目,0%-2.6%接受减重手术。

核心结论

  • 在VHA中,糖尿病和重度肥胖增加NAFLD患者晚期纤维化的风险。
  • 这些患者中仅约20%参加了饮食/运动项目或约2%接受了减重手术。
  • 作者认为,提供者应针对患者调整干预措施以改善结局,尤其是糖尿病和重度肥胖患者。

研究设计与样本

  • 回顾性病例对照研究,从VHA数据库(2005-2015年)随机选取病例,纳入经活检定义的NAFLD或正常肝脏成人患者。
  • 共审查2091例患者,399例符合纳入标准。
  • 正常对照(n=65)肝功能正常;NAFLD队列包括:NAFL脂肪变(n=76)、无纤维化的非酒精性脂肪性肝炎(NASH)(n=68)、NAFLD/NASH 1-3期纤维化(n=82)、NAFLD/NASH肝硬化(n=70)。
  • 另单独识别NAFLD合并肝细胞癌(HCC)患者(n=38)。

主要发现

  • 大多数患者为老年白人男性。
  • 任何纤维化的NAFLD患者平均为重度肥胖(BMI>35 kg/m2)。
  • NAFLD合并纤维化或HCC的患者中糖尿病(54.4%-79.6%)和高血压(85.8%-100%)更常见。
  • 在NAFLD患者中,12.3%-19.5%参加了饮食/运动项目,0%-2.6%接受了减重手术。
  • 西班牙裔的NASH比例较高(20.6%),黑人的NAFLD比例较低(1.4%-11.8%),尤其是NAFLD肝硬化和HCC(1.4%-2.6%)。

临床怎么用

  • 作者认为,提供者应针对患者调整干预措施以改善结局,尤其是糖尿病和重度肥胖患者。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: With its increasing incidence, nonalcoholic fatty liver disease (NAFLD) is of particular concern in the Veterans Health Administration (VHA). AIMS: To evaluate risk factors for advanced fibrosis in biopsy-proven NAFLD in the VHA, to identify patients at risk for adverse outcomes. METHODS: In randomly selected cases from VHA databases (2005-2015), we performed a retrospective case-control study in adults with biopsy-defined NAFLD or normal liver. RESULTS: Of 2091 patients reviewed, 399 met inclusion criteria. Normal controls (n = 65) had normal liver function. The four NAFLD cohorts included: NAFL steatosis (n = 76), nonalcoholic steatohepatitis (NASH) without fibrosis (n = 68), NAFLD/NASH stage 1-3 fibrosis (n = 82), and NAFLD/NASH cirrhosis (n = 70). NAFLD with hepatocellular carcinoma (HCC) was separately identified (n = 38). Most patients were older White men. NAFLD patients with any fibrosis were on average severely obese (BMI>35 kg/m2 ). Diabetes (54.4%-79.6%) and hypertension (85.8%-100%) were more common in NAFLD with fibrosis or HCC. Across NAFLD, 12.3%-19.5% were enrolled in diet/exercise programs and 0%-2.6% had bariatric surgery. Hispanics exhibited higher rates of NASH (20.6%), while Blacks had low NAFLD rates (1.4%-11.8%), particularly NAFLD cirrhosis and HCC (1.4%-2.6%). Diabetes (OR 11.8, P < .001) and BMI (OR 1.4, P < .001) were the most significant predictors of advanced fibrosis. CONCLUSIONS: In the VHA, diabetes and severe obesity increased risk for advanced fibrosis in NAFLD. Of these patients, only a small proportion (~20%) had enrolled in diet/exercise programs or had bariatric surgery (~2%). These results suggest that providers should focus/tailor interventions to improve outcomes, particularly in those with diabetes and severe obesity.

来源:Aliment Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Patel YA, Gifford EJ, Glass LM, et al. Risk factors for biopsy-proven advanced non-alcoholic fatty liver disease in the Veterans Health Administration. Aliment Pharmacol Ther. 2017. PMID: 29115682. doi:10.1111/apt.14411

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。